Henning; Robert Henk

Patent Applications and Registrations

Patent applications and USPTO patent grants for Henning; Robert Henk.The latest application filed is for "medicaments for the treatment of vasoconstriction related diseases or disorders".

Company Profile

3.5.13

Henning; Robert Henk - Groningen NL
Henning; Robert Henk - Loppersum NL
Henning, Robert Henk - AJ Loppersum NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Medicaments For The Treatment Of Vasoconstriction Related Diseases Or Disorders App 20210128523 - Henning; Robert Henk ; et al.	2021-05-06
Compound For The Prophylaxis Or Treatment Of Organ Damage App 20210024485 - van der GRAAF; Adrianus Cornelis ; et al.	2021-01-28
6-chromanol Derivatives For Use As A Medicament App 20200206235 - Henning; Robert Henk ; et al.	2020-07-02
Compound for the prophylaxis or treatment of organ damage Grant 10,676,452 - Van Der Graaf , et al.	2020-06-09
6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases Grant 10,426,771 - Van der Graaf , et al. October 1, 2	2019-10-01
6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases Grant 10,322,124 - Van der Graaf , et al.	2019-06-18
6-hydroxy-2,5,7,8-tetramethylchroman-compounds For The Treatment Of Chronic Obstructive Airway Diseases App 20180280384 - Van der Graaf; Adrianus Cornelis ; et al.	2018-10-04
6-hydroxy-2,5,7,8-tetramethylchroman-compounds For The Treatment Of Chronic Obstructive Airway Diseases App 20180250294 - Van der Graaf; Adrianus Cornelis ; et al.	2018-09-06
Compound For The Prophylaxis Or Treatment Of Organ Dagamage App 20180170892 - VAN DER GRAAF; Adrianus Cornelis ; et al.	2018-06-21
6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases Grant 9,913,841 - Van der Graaf , et al. March 13, 2	2018-03-13
6-Hydroxy-2,5,7,8-Tetramethylchroman-Compounds for the Treatment of Chronic Obstructive Airway Diseases App 20170151234 - Van der Graaf; Adrianus Cornelis ; et al.	2017-06-01
Compounds for Prevention of Cell Injury App 20130203830 - Talaei; Fatemeh ; et al.	2013-08-08
Hsp and Supraventricular Arrhythmia App 20080161258 - Henning; Robert Henk ; et al.	2008-07-03
Use of erythropoietin for the preventive or curative treatment of cardiac failure Grant 7,335,490 - Van Gilst , et al. February 26, 2	2008-02-26
Use of angiotensin-(1-7) for preventing and/or reducing the formation of neointima App 20050142130 - Roks, Antonius Jacobus Marinus ; et al.	2005-06-30
Use of angiotensin 1-7 for enhancing cardiac function App 20050119180 - Roks, Antonius Jacobus Marinus ; et al.	2005-06-02
Gene therapy to promote angiogenesis and/or the treatment of heart failure App 20030073237 - Roks, Antonius Jacobus M. ; et al.	2003-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.